A Chat with Andrew Chancellor, CEO at Wellbeing International

Tell us about Wellbeing International

Wellbeing International Foundation was created to close the gap between scientific discovery and everyday medicine. The aim has always been to turn strong biologic research into treatments that genuinely help people, rather than leaving good science stuck inside laboratories. Our focus is on regenerative medicine and cell-free biologic therapies. These are treatments built from the body’s own healing signals rather than whole cells or surgery.

A defining part of our identity is our commitment to an autologous approach, meaning we only work with material that comes from the patient themselves. This keeps treatments biologically familiar to the body, like using a key cut from the same lock it is meant to open. That sense of natural alignment is important to us. From the beginning, we’ve seen science as something that should serve people. Compassion and clear ethics shape our choices, and if we don’t believe a patient will benefit, we will not offer a service. That principle is one of the things that guides the organisation more strongly than anything else.

What makes Wellbeing International unique?

What makes us different is the space we operate in. The autologous element is a major part of that uniqueness, because it allows us to support treatments that feel natural to the body’s own repair systems. We also recognise an important scientific reality: exosome-only approaches have limitations. Their contents can vary depending on how the donor cells were grown, they don’t carry many of the key soluble factors, like growth signals and structural proteins, needed for full tissue repair, and they don’t trigger the deeper biological resets linked with longer-term rejuvenation.

Research has repeatedly shown that broader conditioned-media approaches offer stronger and more reliable therapeutic effects because they contain the full spectrum of biologic messengers, not just vesicles. Another distinguishing feature is our collaborative culture. We work with researchers, clinicians, and policy specialists as a unified network rather than separate groups. This keeps us grounded in real-world medical needs while still supporting scientific progress.

How has your offering and approach evolved?

We began by focusing on neurodegenerative conditions, reflecting the expertise of our founding scientist, who came from a neuroscience background. As our work developed, we expanded into supporting recovery from sports injuries, where regenerative biology has clear and immediate benefits, and over the years, we have been able to move into new areas as research opens fresh possibilities and gives us the evidence we need to deliver safe, meaningful progress. One major shift has been our evolution into internal anti-ageing and longevity-focused biologic work.

As the science guiding these pathways strengthened, we expanded into helping support the body’s own repair systems from within. We have also grown our digital tools, creating secure platforms for global learning and communication. Alongside this, sustainability is now a core part of our decision-making. Good healthcare considers long-term impact, not just short-term results.

What can we see from Wellbeing International in the future?

Looking forward, the next phase for Wellbeing International Foundation is about scale, openness, and responsible progress. We are widening our network of global partners across Europe, North America, and Asia to push forward non-cellular biologics and other promising regenerative areas. Longevity and internal anti-ageing research will continue to grow, guided by the principle of supporting natural biological repair rather than making extreme claims. Technology will also play a bigger part in what we do. Digital diagnostics, AI-assisted analysis, and secure data systems will help clinicians understand and use regenerative tools more accurately.

We will continue exploring new areas of research while avoiding sensitive or inappropriate medical claims. Through all of this, our core principle remains the same: innovation with integrity. Real progress in regenerative medicine only happens through transparency, collaboration, and empathy, and that is the future we aim to build.